RESEARCH USE ONLY: These products are strictly for laboratory research purposes and not for human consumption.
Ipamorelin
Selective Growth Hormone Secretagogue
Peptide Profile
Aib-His-D-2-Nal-D-Phe-Lys-NH2
711.9 g/mol
For maximum stability, store the lyophilized powder at -20°C (or -80°C for long-term preservation) protected from light and moisture. Once reconstituted with bacteriostatic water or sterile saline, the solution should be kept refrigerated at 2°C to 8°C and utilized within 14–21 days. Avoid repeated freeze-thaw cycles and keep vials tightly sealed until use to maintain compound integrity.
Relevant Literature
Recent in-vitro studies:
Selected in-vitro / cell-based PubMed literature relevant to this compound:
- Reference 1
K Raun et al. (1998). Ipamorelin, the first selective growth hormone secretagogue. Eur J Endocrinol. PMID: 9849822.
View on PubMed - Reference 2
L Jiménez-Reina et al. (2002). Influence of chronic treatment with the growth hormone secretagogue Ipamorelin, in young female rats: somatotroph response in vitro. Histol Histopathol. PMID: 12168778.
View on PubMed - Reference 3
A Thomas et al. (2012). Metabolism of growth hormone releasing peptides. Anal Bioanal Chem. PMID: 23101768.
View on PubMed

